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Abstract
Presented paper describes the results of the individual doses 
measurements for ionizing radiation, carried out by the Labora-
tory of Individual and Environmental Doses Monitoring (PDIS) 
of the Central Laboratory for Radiological Protection in Warsaw 
(CLOR) for the medical staff employees in several nuclear 
medicine (NM) departments across Poland. In total there are 
48 NM departments in operation in Poland [1] (consultation in 
Nuclear Atomic Agency). Presented results were collected over 
the period from January 2011 to December 2011 at eight NM 
departments located in Krakow, Warszawa (two departments), 
Rzeszow (two departments), Opole, Przemysl and Gorzow 
Wielkopolski. For radiation monitoring three kinds of thermolumi-
nescence dosimeters (TLD) were used. The first TLD h collected 
information about whole body (C) effective dose, the second 
dosimeter was mounted in the ring (P) meanwhile the third on the 
wrist (N) of the tested person. Reading of TLDs was performed 
in quarterly periods. As a good approximation of effective and 
equivalent dose assessment of operational quantities both the 
individual dose equivalent Hp(10) and the Hp(0.07) were used. 
The analysis of the data was performed using two methods The 
first method was based on quarterly estimations of Hp(10)q and 
Hp(0.07)q while the second measured cumulative annual doses 
Hp(10)a and Hp(0.07)a. The highest recorded value of the radia-
tion dose for quarterly assessments reached 24.4 mSv and was 
recorded by the wrist type dosimeter worn by a worker involved 
in source preparation procedure. The mean values of Hp(10)q 
(C type dosimeter) and Hp(0.07)q (P and N type dosimeter) for 
all monitored departments were respectively 0.46 mSv and 3.29 
mSv. There was a strong correlation between the performed job 
and the value of the received dose. The highest doses always 
were absorbed by those staff members who were involved in 
sources preparation. The highest annual cumulative dose for 
a particular worker in the considered time period was 4.22 
mSv for Hp(10)a and 67.7 mSv for Hp(0.07)a. In 2011 no case 
of exceeding the allowed dose limits was noted.
KEY words: dose monitoring, TLD, occupational exposure, 
individual dose equivalent, dose limits
Nuclear Med Rev 2013; 16, 2: 62–65
Introduction
The safety of employees in nuclear medicine who are exposed 
to ionizing radiation is regulated by the act of parliament, known 
as Atomic Law [2]. According to this document two categories of 
workers, depending on magnitude of exposure has been estab-
lished: category A are workers who may be exposed to an effective 
dose (E) exceeding 6 mSv in one year or to an equivalent dose 
(H) exceeding three-tenth of the dose limits for eye lens, skin 
and extremities; category B are workers who may be exposed to 
an effective dose exceeding 1 mSv in one year or to an equivalent 
dose exceeding one-tenth of the dose limits for eye lens, skin and 
extremities (see Table 1).
Radioactive sources used in nuclear medicine departments al-
ways have an open character. Because of that all NM employees in-
volved in procedures that require contact with radioactive material 
(such as o preparation of radiopharmaceuticals, patients’ injections, 
measurement of radio-markers positioned inside of patient body 
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and all other contacts with treated or diagnosed patients) belong 
to “A” category of workers. For A category the quantities considered 
by the appropriate limits are as follows: the effective dose for the 
whole body exposure, and the equivalent dose for exposure of 
certain tissues or organs, as indicated by ICRP Publication 60 [3]. 
Because of effective dose and equivalent dose are immeasurable 
directly the operational quantities as Hp(10) for E and Hp(0.07) for 
H are used as a good approximation.
Doses monitoring service in CLOR has been established in 1956 
and presently it works as the Laboratory of Individual and Environ-
mental Doses. In December 2003 the Laboratory was approved 
by the Polish Centre for Accreditation and was granted Accredita-
tion Certiﬁ cate (Nr AB 450) which was a necessary condition to 
continue providing radiation monitoring service in Poland. In 1999 
RADOS TLD system including Dosacus reader, 4000 LiF:Mg,Ti,S 
thermoluminescence pellets and 4000 whole body dosimeters were 
put into operation. 
In nuclear medicine procedures the following radionuclides are 
most often used: 11C, 18F, 111In, 123I, 125I, 131I, 15O, 32P, 99mTc and 90Y. All 
of them emit gamma radiation with energies ranging from 25 keV 
to 511 keV. The range of used activities is wide as they depend 
on the applied procedures. They typically vary from the tenths of 
MBq in case of thyroid function study and reach even a few GBq 
in carcinoma treatment cases. 
Material and methods
For each individual dose monitoring procedure the TLD method 
based on MCP-N (LiF:Mg,Cu,P) thermoluminescent material 
was used. The material employed in TLD dosimeter is characterized 
by high sensitivity [4] for radiation detection and very low detection 
limit which is 60 nGy for air kerma [5]. 
According to the quality system implemented in the Laboratory 
read-out, dose calculation and calibration processes are performed 
accordingly to the accredited internal procedures [6]. Additionally 
to prove suitability of the used methods Laboratory periodically 
participates in international comparisons. 
For dosimeters worn on chest (type C) the operational quantity 
used for estimation of the effective dose is the individual dose equiva-
lent Hp(10). For dosimeters worn on a ﬁ nger (type P) or wrist (type 
N) operational quantity is the individual dose equivalent Hp(0.07).
Results of monitoring are held in SQL database which pro-
vides internet access to the mentioned data for the monitored 
institution and for administrator of the system in CLOR. For every 
monitored nuclear medicine department a special information 
card is maintained. The card includes information regarding 
the types and activities of radioactive sources that are used in 
this particular department, as well as the character of work for all 
employed persons. The detection limit of CLOR monitoring sys-
tems is 0.1 mSv and the standard monitoring period is three months.
For our study two kinds of analyses have been performed. 
The ﬁ rst was based on quarterly doses: Hp(10)q and Hp(0.07)q, 
the second on annual cumulative doses: Hp(10)a and Hp(0.07)a. 
In both of them the maximum and the mean value were obtained 
independently for Hp(10) and Hp(0.07). For the purpose of an-
nual analysis the cumulative annual doses Hp(10)a and Hp(0.07)a 
received by each individual employee were used. 
The results were additionally referenced to the value of dose 
received from natural radiation and values of average annual 
doses in other sectors as was reported before [7] . 
Results and discussion
In total 525 quarterly readouts were made in eight nuclear medi-
cine departments controlled by CLOR in the period from January 
2011 up to the end of December 2011. Almost 67% of them were 
related to Hp(10) estimation. All the analysed dosimeters were 
exposed for ionizing radiation during routine activities performed 
by persons employed in NM departments. Any case where the 
allowed dose limits was exceeded was recorded.
Based on the data taken from the information cards established 
for individual departments, a close correlation between the received 
doses and job character was observed. During each monitoring 
period the highest doses were received by the technicians respon-
sible for preparation of radioactive sources or its application to the 
patient. Our investigation showed that the received doses remained 
in good agreement with the level of radioiodine and technetium 
deposition in the thyroid as it was shown in before investigation [8]. 
Table 2 presents the maximum and the mean values for quarterly 
and annual doses assessment. 
Analysis of Hp(10)q and Hp(0.07)q 
The maximum quarterly dose Hp(10)q observed during the men-
tioned period was equal to 1.37 mSv. As is presented in Figure 1, 
more than 98% of Hp(10)q of the obtained dose estimations resulted 
in the Hp(10) values lower than1mSv while the most frequently 
obtained doses balanced around 0.25 mSv. The mean value of 
Hp(10)q in the considered period and all departments was 0.46 mSv. 
For Hp(0.07)q maximum recorded dose have been observed for 
the N type dosimeter and it amounted to 24.4 mSv. Though there 
was a slight increase of frequency for estimation of dose around 
12 mSv, see Figure 2 more than 72% of Hp(0.07)q results were below 
1 mSv. The mean value for Hp(0.07)q estimation was 3.29 mSv. 
Table 1. Dose limits for different operational dose quantities. E — 
effective dose, H — equivalent dose for adequate tissue or organ
Category A Category B
Hole body 6 mSv < E ≤ 20 mSv 1 mSv < E ≤ 6 mSv
Eye lens 45 mSv < H < 150 mSv 15 mSv < H ≤ 45 mSv 
Extremities 
and skin
150 mSv < H < 500 mSv 50 mSv < H ≤ 150 mSv
Table 2. The maximum and the mean values of quarterly and an-
nual doses  received by the employees performing radioactive 
procedures in the eight NM departments analysed in this study
Quarterly Max value, mSv Mean value, mSv Below 1 mSv, %
Hp(10)q 1.37 0.46 98.2
Hp(0.07)q 24.4 3.29 72.3
Annual Max value, mSv Mean value, mSv Below 1 mSv, %
Hp(10)a 4.22 1.12 57
Hp(0.07)a 67.7 11.9 34.3
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Analysis of Hp(10)a and Hp(0.07)a 
Based on the data collected in 2011, our study has found that 
the maximum annual personal dose Hp(10)a in the eight analysed 
departments was equal to 4.22 mSv. Figure 3 presents the results of 
annual cumulative doses Hp(10)a which show that 57% of doses re-
mained below 1 mSv. The mean Hp(10)a value was 1.12 mSv. These 
values can be compared to the mean annual dose received by 
an individual from naturally occurred radiation that is estimated to 
be equal in Poland to 2.9 mSv [9].
The maximum values of Hp(0.07)a estimation was 67.7 mSv that 
was about one tents of the dose limit for type A workers for extremi-
ties which amount to 500 mSv. The hands are the most exposed 
part of the body during nuclear medicine procedures so almost 
66% of Hp(0.07)a estimation values were above 1 mSv, see Figure 
4. The mean value for Hp(0.07)a was 11.9 mSv. In the considered 
period of time any case exceeding currently applicable dose lim-
its have been noted. 
Figure 4. Distribution of annual cumulative Hp(0.07)a estimation in 2011
Table 3. Comparison of average annual dose in different work sectors
Average annual dose Hp(10)
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Figure 1. Distribution of quarterly Hp(10)q estimations
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Figure 2. Distribution of quarterly Hp(0.07)q estimations
Figure 3. Distribution of annual cumulative Hp(10)a estimation in 2011
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Basing on before investigation [7] the results can be compared 
with annual average doses in other sectors where the radioactive 
sources are used (see Table 3).
Conclusions
The TLD-based individual doses monitoring method, especially 
monitoring based on the use of extremities dosimeters, is a mo-
dern technique fully applicable in nuclear medicine departments. 
Individual doses monitoring performed for eight NMD showed that 
personnel in that kind of medical institution should be carefully 
monitored especially by using extremities dosimeters because 
of high risk of exposure of theirs hands during manipulations of 
radioactive sources. In addition, staff should be under permanent 
dose control to provide information about situations exceeding 
allowed dose limits. Special attention should be paid to properly 
established dose constraints. For example, as a good practice 
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that should be implemented, would be dividing some of the most 
hazardous activities (such as preparation of high activity sources) 
to as many workers as possible.
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